チロシンキナーゼ阻害剤のグローバル市場2023-2027:RTKI、nRTKI

■ 英語タイトル:Global Tyrosine Kinase Inhibitors Market 2023-2027

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR74141-23)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR74141-23
■ 発行日:2023年5月30日
■ 調査対象地域:グローバル
■ 産業分野:医薬品
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[チロシンキナーゼ阻害剤のグローバル市場2023-2027:RTKI、nRTKI]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

チロシンキナーゼ阻害剤の世界市場 2023-2027
チロシンキナーゼ阻害剤市場は、2022年から2027年にかけて241.2億米ドルに達し、予測期間中はCAGR 8.93%拡大すると予測されています。この調査レポートは、チロシンキナーゼ阻害剤市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに、約25社の企業を網羅した企業分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。この市場は、チロシンキナーゼ阻害剤の高い標的親和性と特異性、患者支援プログラムの利用可能性の上昇、世界的ながんの有病率の増加などが牽引しています。

Technavio社のチロシンキナーゼ阻害剤市場は以下のように区分されています:

・製品別
– RTKIs
– nRTKIs

・販売チャネル別
– オフライン
– オンライン

・地域別
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、今後数年間のチロシンキナーゼ阻害剤市場の成長を促進する主要要因の一つとして、市場ベンダー間の戦略的提携を挙げています。また、チロシンキナーゼ阻害剤治療における研究領域の拡大や、バイオシミラーの上市の増加は、市場の大きな需要につながると見込んでいます。

チロシンキナーゼ阻害剤市場に関する本レポートは、以下の分野を網羅しています:
– チロシンキナーゼ阻害剤市場のサイジング
– チロシンキナーゼ阻害剤市場の予測
– チロシンキナーゼ阻害剤市場の産業分析

堅実な企業分析は、顧客が市場での地位を向上させるのに役立つよう設計されており、これに沿って、本レポートでは、AbbVie Inc., Amgen Inc., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Eisai Co. Ltd., Eli Lilly and Co., Exelixis Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Incyte Corp., Johnson and Johnson Services Inc., Novartis AG, Pfizer Inc., Puma Biotechnology Inc., Regeneron Pharmaceuticals Inc., Rigel Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., Viatris Inc.が含まれています。なお、チロシンキナーゼ阻害剤市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も記載されています。これは、今後の成長機会のための企業戦略・レバレッジに役立つものです。

本調査は、産業の主要参加者からの情報提供を含め、一次情報と二次情報を客観的に組み合わせて行われました。本レポートには、主要企業の分析に加え、包括的な市場・企業状況が含まれています。

Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で市場の詳細な姿を提示しています。また、主要な産業インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密な企業選定方法と分析を提供します。

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global tyrosine kinase inhibitors market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global tyrosine kinase inhibitors market 2017 – 2021 ($ billion)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
o 4.3 Distribution channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 RTKIs – Market size and forecast 2022-2027
o Exhibit 34: Chart on RTKIs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on RTKIs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on RTKIs – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on RTKIs – Year-over-year growth 2022-2027 (%)
o 6.4 nRTKIs – Market size and forecast 2022-2027
o Exhibit 38: Chart on nRTKIs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on nRTKIs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on nRTKIs – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on nRTKIs – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ billion)
o Exhibit 43: Data Table on Market opportunity by Product ($ billion)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Offline – Market size and forecast 2022-2027
o Exhibit 48: Chart on Offline – Market size and forecast 2022-2027 ($ billion)
o Exhibit 49: Data Table on Offline – Market size and forecast 2022-2027 ($ billion)
o Exhibit 50: Chart on Offline – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Offline – Year-over-year growth 2022-2027 (%)
o 7.4 Online – Market size and forecast 2022-2027
o Exhibit 52: Chart on Online – Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Data Table on Online – Market size and forecast 2022-2027 ($ billion)
o Exhibit 54: Chart on Online – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Online – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 56: Market opportunity by Distribution Channel ($ billion)
o Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 63: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 64: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 68: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 72: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 79: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 83: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 87: Chart on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 91: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Canada – Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 107: AbbVie Inc. – Overview
o Exhibit 108: AbbVie Inc. – Product / Service
o Exhibit 109: AbbVie Inc. – Key news
o Exhibit 110: AbbVie Inc. – Key offerings
o 12.4 Amgen Inc.
o Exhibit 111: Amgen Inc. – Overview
o Exhibit 112: Amgen Inc. – Product / Service
o Exhibit 113: Amgen Inc. – Key offerings
o 12.5 AstraZeneca PLC
o Exhibit 114: AstraZeneca PLC – Overview
o Exhibit 115: AstraZeneca PLC – Product / Service
o Exhibit 116: AstraZeneca PLC – Key news
o Exhibit 117: AstraZeneca PLC – Key offerings
o 12.6 Bayer AG
o Exhibit 118: Bayer AG – Overview
o Exhibit 119: Bayer AG – Business segments
o Exhibit 120: Bayer AG – Key news
o Exhibit 121: Bayer AG – Key offerings
o Exhibit 122: Bayer AG – Segment focus
o 12.7 Boehringer Ingelheim International GmbH
o Exhibit 123: Boehringer Ingelheim International GmbH – Overview
o Exhibit 124: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 125: Boehringer Ingelheim International GmbH – Key news
o Exhibit 126: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 127: Boehringer Ingelheim International GmbH – Segment focus
o 12.8 Bristol Myers Squibb Co.
o Exhibit 128: Bristol Myers Squibb Co. – Overview
o Exhibit 129: Bristol Myers Squibb Co. – Product / Service
o Exhibit 130: Bristol Myers Squibb Co. – Key news
o Exhibit 131: Bristol Myers Squibb Co. – Key offerings
o 12.9 Eisai Co. Ltd.
o Exhibit 132: Eisai Co. Ltd. – Overview
o Exhibit 133: Eisai Co. Ltd. – Business segments
o Exhibit 134: Eisai Co. Ltd. – Key offerings
o Exhibit 135: Eisai Co. Ltd. – Segment focus
o 12.10 Eli Lilly and Co.
o Exhibit 136: Eli Lilly and Co. – Overview
o Exhibit 137: Eli Lilly and Co. – Product / Service
o Exhibit 138: Eli Lilly and Co. – Key news
o Exhibit 139: Eli Lilly and Co. – Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 140: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 141: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 142: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 143: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 144: F. Hoffmann La Roche Ltd. – Segment focus
o 12.12 GlaxoSmithKline Plc
o Exhibit 145: GlaxoSmithKline Plc – Overview
o Exhibit 146: GlaxoSmithKline Plc – Business segments
o Exhibit 147: GlaxoSmithKline Plc – Key news
o Exhibit 148: GlaxoSmithKline Plc – Key offerings
o Exhibit 149: GlaxoSmithKline Plc – Segment focus
o 12.13 Incyte Corp.
o Exhibit 150: Incyte Corp. – Overview
o Exhibit 151: Incyte Corp. – Product / Service
o Exhibit 152: Incyte Corp. – Key offerings
o 12.14 Johnson and Johnson Services Inc.
o Exhibit 153: Johnson and Johnson Services Inc. – Overview
o Exhibit 154: Johnson and Johnson Services Inc. – Business segments
o Exhibit 155: Johnson and Johnson Services Inc. – Key news
o Exhibit 156: Johnson and Johnson Services Inc. – Key offerings
o Exhibit 157: Johnson and Johnson Services Inc. – Segment focus
o 12.15 Novartis AG
o Exhibit 158: Novartis AG – Overview
o Exhibit 159: Novartis AG – Business segments
o Exhibit 160: Novartis AG – Key offerings
o Exhibit 161: Novartis AG – Segment focus
o 12.16 Pfizer Inc.
o Exhibit 162: Pfizer Inc. – Overview
o Exhibit 163: Pfizer Inc. – Product / Service
o Exhibit 164: Pfizer Inc. – Key news
o Exhibit 165: Pfizer Inc. – Key offerings
o 12.17 Viatris Inc.
o Exhibit 166: Viatris Inc. – Overview
o Exhibit 167: Viatris Inc. – Business segments
o Exhibit 168: Viatris Inc. – Key news
o Exhibit 169: Viatris Inc. – Key offerings
o Exhibit 170: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 171: Inclusions checklist
o Exhibit 172: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 173: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 174: Research methodology
o Exhibit 175: Validation techniques employed for market sizing
o Exhibit 176: Information sources
o 13.5 List of abbreviations
o Exhibit 177: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global tyrosine kinase inhibitors market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on RTKIs – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on RTKIs – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on RTKIs – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on RTKIs – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on nRTKIs – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on nRTKIs – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on nRTKIs – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on nRTKIs – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ billion)
Exhibits43: Data Table on Market opportunity by Product ($ billion)
Exhibits44: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Offline – Market size and forecast 2022-2027 ($ billion)
Exhibits49: Data Table on Offline – Market size and forecast 2022-2027 ($ billion)
Exhibits50: Chart on Offline – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Offline – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Online – Market size and forecast 2022-2027 ($ billion)
Exhibits53: Data Table on Online – Market size and forecast 2022-2027 ($ billion)
Exhibits54: Chart on Online – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Online – Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Distribution Channel ($ billion)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits64: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits65: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits68: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits69: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits72: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits73: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ billion)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: AbbVie Inc. – Overview
Exhibits108: AbbVie Inc. – Product / Service
Exhibits109: AbbVie Inc. – Key news
Exhibits110: AbbVie Inc. – Key offerings
Exhibits111: Amgen Inc. – Overview
Exhibits112: Amgen Inc. – Product / Service
Exhibits113: Amgen Inc. – Key offerings
Exhibits114: AstraZeneca PLC – Overview
Exhibits115: AstraZeneca PLC – Product / Service
Exhibits116: AstraZeneca PLC – Key news
Exhibits117: AstraZeneca PLC – Key offerings
Exhibits118: Bayer AG – Overview
Exhibits119: Bayer AG – Business segments
Exhibits120: Bayer AG – Key news
Exhibits121: Bayer AG – Key offerings
Exhibits122: Bayer AG – Segment focus
Exhibits123: Boehringer Ingelheim International GmbH – Overview
Exhibits124: Boehringer Ingelheim International GmbH – Business segments
Exhibits125: Boehringer Ingelheim International GmbH – Key news
Exhibits126: Boehringer Ingelheim International GmbH – Key offerings
Exhibits127: Boehringer Ingelheim International GmbH – Segment focus
Exhibits128: Bristol Myers Squibb Co. – Overview
Exhibits129: Bristol Myers Squibb Co. – Product / Service
Exhibits130: Bristol Myers Squibb Co. – Key news
Exhibits131: Bristol Myers Squibb Co. – Key offerings
Exhibits132: Eisai Co. Ltd. – Overview
Exhibits133: Eisai Co. Ltd. – Business segments
Exhibits134: Eisai Co. Ltd. – Key offerings
Exhibits135: Eisai Co. Ltd. – Segment focus
Exhibits136: Eli Lilly and Co. – Overview
Exhibits137: Eli Lilly and Co. – Product / Service
Exhibits138: Eli Lilly and Co. – Key news
Exhibits139: Eli Lilly and Co. – Key offerings
Exhibits140: F. Hoffmann La Roche Ltd. – Overview
Exhibits141: F. Hoffmann La Roche Ltd. – Business segments
Exhibits142: F. Hoffmann La Roche Ltd. – Key news
Exhibits143: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits144: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits145: GlaxoSmithKline Plc – Overview
Exhibits146: GlaxoSmithKline Plc – Business segments
Exhibits147: GlaxoSmithKline Plc – Key news
Exhibits148: GlaxoSmithKline Plc – Key offerings
Exhibits149: GlaxoSmithKline Plc – Segment focus
Exhibits150: Incyte Corp. – Overview
Exhibits151: Incyte Corp. – Product / Service
Exhibits152: Incyte Corp. – Key offerings
Exhibits153: Johnson and Johnson Services Inc. – Overview
Exhibits154: Johnson and Johnson Services Inc. – Business segments
Exhibits155: Johnson and Johnson Services Inc. – Key news
Exhibits156: Johnson and Johnson Services Inc. – Key offerings
Exhibits157: Johnson and Johnson Services Inc. – Segment focus
Exhibits158: Novartis AG – Overview
Exhibits159: Novartis AG – Business segments
Exhibits160: Novartis AG – Key offerings
Exhibits161: Novartis AG – Segment focus
Exhibits162: Pfizer Inc. – Overview
Exhibits163: Pfizer Inc. – Product / Service
Exhibits164: Pfizer Inc. – Key news
Exhibits165: Pfizer Inc. – Key offerings
Exhibits166: Viatris Inc. – Overview
Exhibits167: Viatris Inc. – Business segments
Exhibits168: Viatris Inc. – Key news
Exhibits169: Viatris Inc. – Key offerings
Exhibits170: Viatris Inc. – Segment focus
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR74141-23 )"チロシンキナーゼ阻害剤のグローバル市場2023-2027:RTKI、nRTKI" (英文:Global Tyrosine Kinase Inhibitors Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。